Variants of bovine pancreatic trypsin inhibitor and pharmaceutical use thereof
US5118668A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jul 20, 1988 |
| Grant date | Jun 2, 1992 |
| Priority date | — |
| Expiry date | Jul 20, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptides having essentially the sequence of bovine pancreatic trypsin inhibitor (aprotinin) wherein one or more of the amino acids at positions 15, 16, 17, 18, 34, 39 and 52 are replaced by any naturally occurring amino acid produced by recombinant DNA technology, process, expression vector and recominant host therefor and pharmaceutical use thereof. Such peptides being useful as therapeutic agents in diseases connected with the presence of excessive amounts of proteinases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.